| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.5M | -43.0% |
| SG&A Expense | $11.4M | -16.1% |
| Operating Income | -$16.8M | +27.2% |
| Pre-tax Income | -$10K | +99.9% |
| Income Tax | $0 | — |
| Net Income | -$10.0M | +43.6% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | -71.0% |
| Current Assets | $4.3M | -68.6% |
| Total Assets | $4.4M | -68.5% |
| Total Liabilities | $4.6M | -61.9% |
| Stockholders' Equity | -$229K | -112.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.4M | +23.6% |
| Financing Cash Flow | $7.0M | -72.2% |